Extralabel intramammary use of drugs in dairy cattle

Journal of the American Veterinary Medical Association

Volumn 226, Issue 12, 2005, Pages 1994-1996

  Smith, Geof W ^a   Gehring, Ronette ^a   Craigmill, Arthur L ^b   Webb, Alistair I ^c   Riviere, Jim E ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c University of Florida College of Veterinary Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTIOFUR; CHLORAMPHENICOL; CHLORHEXIDINE; DIMETHYL SULFOXIDE; ENROFLOXACIN; FLORFENICOL; GENTAMICIN; OXYTETRACYCLINE; POLYMYXIN B; POVIDONE IODINE; SULFONAMIDE; TILMICOSIN;

CATTLE DISEASE; DAIRY CATTLE; DRUG ABSORPTION; DRUG APPROVAL; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG EXCRETION; DRUG FORMULATION; DRUG HALF LIFE; DRUG INDICATION; DRUG LABELING; DRUG MILK LEVEL; DRUG TISSUE LEVEL; DRUG URINE LEVEL; DRUG USE; MASTITIS; NEPHROTOXICITY; NONHUMAN; SHORT SURVEY;

ANIMALS; ANTI-BACTERIAL AGENTS; CATTLE; FEMALE; LEGISLATION, VETERINARY; MASTITIS, BOVINE; UNITED STATES; VETERINARY DRUGS;

BOS TAURUS;

EID: 20444450910     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.2005.226.1994     Document Type: Short Survey

References (14)

1. Smith GW, Gehring R, Riviere JE, et al. Elimination kinetics of ceftiofur hydrochloride after intramammary administration in lactating dairy cows. J Am Vet Med Assoc 2004;224:1827-1830.
2. Middleton JR, Hebert VR, Fox LK, et al. Elimination kinetics of chlorhexidine in milk following intramammary infusion to stop lactation in mastitic mammary gland quarters of cows. J Am Vet Med Assoc 2003;222:1746-1749.
3. US FDA. Tolerances for residues of new animal drugs in food: chlorhexidine. In: Title 21 code of federal regulations. Washington, DC: Office of the Federal Register National Archives and Records Administration, 2002;556:120.
4. Soback S, Paape MJ, Filep R, et al. Florfenicol pharmacokinetics in lactating cows after intravenous, intramuscular and intramammary administration. J Vet Pharmacol Ther 1995;18:413-417.
5. US FDA, Center for Food Safety and Applied Nutrition. 2003 annual report of the National Milk Drug Residue Database. Available at: www.cfsan.fda.gov/ ~ear/milkrp03.html. Accessed Jul 8, 2004.
6. USDA, Food Safety and Inspection Service, National Residue Program. 2000 National Residue Program data: the "red book." Available at: www.fsis.usda.gov/Frame/FrameRedirect. asp?main=/oppde/ric/links.htm. Accessed Jun 29, 2004.
7. Pedersoli WM, Jackson J, Frobish RA. Depletion of gentamicin in the milk of Holstein cows after single and repeated intramammary and parenteral treatments. J Vet Pharamcol Ther 1995;18: 457-463.
8. Morin DE, Shanks RD, McCoy GC. Comparison of antibiotic administration in conjunction with supportive measures versus supportive measures alone for treatment of dairy cows with clinical mastitis. J Am Vet Med Assoc 1998;213:676-684.
9. Anderson KL, Moats WA, Rushing JE, et al. Potential for oxytetracycline administration by three routes to cause milk residues in lactating cows, as detected by radioimmunoassay (Charm II) and high-performance liquid chromatography test methods. Am J Vet Res 1995;56:70-77.
10. Nagy J, Bartko P, Sokol J, et al. Excretion of oxytetracycline residues in the milk of cows after Tetradue L. A.-300 inj. administration. Folia Vet 1999;41:125-128.
11. Katz SE, Fassbender CA, Hackett AJ, et al. Oxytetracycline residues in milk following intramammary infusion. J Assoc Off Anal Chem 1973;56:706-712.
12. Ziv G, Schultze WD. Pharmacokinetics of polymyxin B administered via the bovine mammary gland. J Vet Pharmacol Ther 1982;5:123-129.
13. Middleton JR, Fox LK. Therapeutic cessation of lactation of Staphylococcus aureus-infected mammary quarters. J Dairy Sci 2001; 84:1976-1978.
14. Payne MA, Baynes RE, Sundlof SF, et al. Drugs prohibited from extralabel use in food animals. J Am Vet Med Assoc 1999;215:28-32.